Valeant Appoints Former Zoetis Exec as CFO
August 23, 2016
Valeant Pharmaceuticals International, Inc. (Laval, Quebec, Canada) announced that Paul S. Herendeen has been appointed Executive Vice President, Finance and will take over the role of Chief Financial Officer from Robert L. Rosiello, effective immediately. Mr. Herendeen joins Valeant from animal health company Zoetis (Florham Park, NJ), where he served as Executive Vice President and CFO for the past two years. Mr. Rosiello will remain at Valeant as Executive Vice President, Corporate Development and Strategy.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
